Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
CAR T Cells Show Solid Progress
Tumors are Being Deprived of Cover by New CAR T-Cell Technologies
Another "CRISPR Calamity"? U.K. Team Reports CRISPR-Induced Gene Rearrangements
New Findings Call the Precision of CRISPR-Cas9 Gene Editing into Question
Enabling the Rise of a CRISPR World
As the World Debates Genome Editing Regulations, the Scientific Community Continues the Push to Democratize CRISPR
For full access to this article login to GEN Select now.
Roslin Cells & Lonza Take On Stem Cell Media
Ultimate Goal of Initiatives Is to Facilitate Translation of Innovation into Regenerative Therapies
- Earlier this year Roslin Cells and Lonza signed a stem cell media development deal the firms hope will play a key role in the drive to translate scientific innovation in the stem cells field into clinically applied regenerative therapies. The agreement is centered on the development of clinical-grade ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.